Postępy w Kardiologii Interwencyjnej

Non-inferiority of a paclitaxel-coated balloon versus a rapamycin-eluting metal stent for de novo non-complex small coronary vessel disease: a prospective randomized controlled trial

XiaoYu Xu 1
,
Yi Xiang 1
,
KangHui Ge 1
,
HaoTian Shi 1
,
ZiWei Zhang 1
,
JiaLin Zheng 1

  1. Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Kunming City, China

Adv Interv Cardiol

DOI: https://doi.org/10.5114/aic.2026.164688
Data publikacji online: 2026/09/13
Article file
Non-inferiority.pdf
  1. Li K, Li K, Yao Q, et al. The potential relationship of coronary artery disease and hyperuricemia: a cardiometabolic risk factor. Heliyon 2023; 9: e16097.
  2. Shao C, Wang J, Tian J, et al. Coronary artery disease: from mechanism to clinical practice. Adv Exp Med Biol 2020; 1177: 1-36.
  3. Rykowska I, Nowak I, Nowak R. Drug-eluting stents and balloons-materials, structure designs, and coating techniques: a review. Molecules 2020; 25: 4624.
  4. Hong SJ, Hong MK. Drug-eluting stents for the treatment of coronary artery disease: a review of recent advances. Expert Opin Drug Deliv 2022; 19: 269-80.
  5. Hu T, Yang J, Cui K, et al. Controlled slow-release drug-eluting stents for the prevention of coronary restenosis: recent progress and future prospects. ACS Appl Mater Interfaces 2015; 7: 11695-712.
  6. Gao C, He X, Ouyang F, et al. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial. Lancet 2024; 404: 1040-50.
  7. Felbel D, Bozic F, Mayer B, et al. Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease-a meta-analysis. Front Cardiovasc Med 2023; 10: 1213992.
  8. Lin L, Lu W, Wang X, et al. Short-term outcomes of drug-coated balloon versus drug-eluting stent for de novo saphenous vein graft lesions in coronary heart disease. Front Cardiovasc Med 2023; 10: 982880.
  9. Mutema M, Shenoy V, Sardar P, et al. Systematic review on role of drug eluting stent (DES) versus drug-coated balloon (DCB) in small vessel coronary artery disease. Curr Cardiol Rep 2024; 26: 681-8.
  10. Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: Third Report of the International DCB Consensus Group. JACC Cardiovasc Interv 2020; 13: 1391-402.
  11. Giacoppo D, Alvarez-Covarrubias HA, Koch T, et al. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial. Eur Heart J 2023; 44: 1343-57.
  12. Abdelaziz A, Elsayed H, Atta K, et al. Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis. BMC Cardiovasc Disord 2025; 25: 339.
  13. Shin ES, Jun EJ, Kim S, et al. Clinical impact of drug-coated balloon-based percutaneous coronary intervention in patients with multivessel coronary artery disease. JACC Cardiovasc Interv 2023; 16: 292-9.
  14. Jensen LO, Thayssen P, Christiansen EH, et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: 5-year results from SORT OUT IV. J Am Coll Cardiol 2016; 67: 751-62.
  15. Borovac JA, D’Amario D, Vergallo R, et al. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother 2019; 5: 105-16.
  16. Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol 2020; 17: 37-51.
  17. Ahmad WAW, Nuruddin AA, Abdul Kader M, et al. Treatment of coronary de novo lesions by a sirolimus- or paclitaxel-coated balloon. JACC Cardiovasc Interv 2022; 15: 770-9.
  18. Huo G, Xue J, Zheng J, et al. Factors associated with patency following drug-coated balloon angioplasty of hemodialysis access. Sci Rep 2025; 15: 19375.
  19. Refaat H, Arab M. Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease. Indian Heart J 2025; 77: 267-74.
  20. Shin ES, Lee JM, Her AY, et al. Prospective randomized trial of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo coronary artery lesions. Coron Artery Dis 2019; 30: 425-31.
  21. Liu Y, Zhang B, Lv H, et al. Drug-coated balloon for de-novo coronary artery lesions exceeding 2.5 mm in diameter: optical coherence tomography analysis and clinical follow-up. Int J Gen Med 2024; 17: 225-36.
  22. Yamamoto M, Hara H, Kubota S, et al. Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions. EuroIntervention 2024; 20: 602-12.
  23. Mahajan N, Singal G, Sharma M. Comparative outcomes of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Arch Med Sci Atheroscler Dis 2025; 10: e167-71.
  24. Niu J, Wang K, Wang W, et al. Drug-coated balloons versus drug-eluting stents for the treatment of de novo coronary artery disease: a meta-analysis of randomized controlled trials. Rev Cardiovasc Med 2024; 25: 446.
  25. Kleber FX, Rittger H, Ludwig J, et al. Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol 2016; 105: 613-21.
  26. Abbasnezhad N, Zirak N, Champmartin S, et al. An overview of in vitro drug release methods for drug-eluting stents. Polymers 2022; 14: 2751.
  27. Cortese B, Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data. Int J Cardiol 2012; 161: 4-12.
  28. Gobić D, Tomulić V, Lulić D, et al. Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study. Am J Med Sci 2017; 354: 553-60.
  29. García-Touchard A, Sabaté M, Gonzalo N, et al. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study). Cardiovasc Diagn Ther 2023; 13: 792-804.
  30. Zhang Y, Li W, Zhang L. Efficacy and safety of drug-eluting stents versus bare-metal stents in symptomatic intracranial and vertebral artery stenosis: a meta-analysis. Front Neurol 2024; 15: 1389254.
  31. Scheller B, Rissanen TT, Farah A, et al. Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 Trial. Circ Cardiovasc Interv 2022; 15: e011569.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications